Anticoagulants in COVID-19: Is there a role for a D-dimer-driven dosing ?
Ö. Unat (Izmir, Turkey), Z. Karimov (Izmir, Turkey), D. Serce Unat (Izmir, Turkey), G. Damar (Izmir, Turkey), P. Caglayan (Izmir, Turkey), F. Teymurlu (Izmir, Turkey), M. Tasbakan (Izmir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), O. Kacmaz Basoglu (Izmir, Turkey), M. Hikmet Özhan (Izmir, Turkey), A. Sayiner (Izmir, Turkey)
Source: International Congress 2022 – Suspicion and management of pulmonary embolism
Session: Suspicion and management of pulmonary embolism
Session type: Thematic Poster
Number: 1191
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ö. Unat (Izmir, Turkey), Z. Karimov (Izmir, Turkey), D. Serce Unat (Izmir, Turkey), G. Damar (Izmir, Turkey), P. Caglayan (Izmir, Turkey), F. Teymurlu (Izmir, Turkey), M. Tasbakan (Izmir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), O. Kacmaz Basoglu (Izmir, Turkey), M. Hikmet Özhan (Izmir, Turkey), A. Sayiner (Izmir, Turkey). Anticoagulants in COVID-19: Is there a role for a D-dimer-driven dosing ?. 1191
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|